Detalhe da pesquisa
1.
Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
Cancer Chemother Pharmacol
; 49(3): 201-10, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11935212
2.
Urinary and fecal excretion of topotecan in patients with malignant solid tumours.
Cancer Chemother Pharmacol
; 50(1): 59-64, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12111113
3.
Safety and efficacy of patupilone in patients with advanced ovarian, primary fallopian, or primary peritoneal cancer: a phase I, open-label, dose-escalation study.
J Clin Oncol
; 27(19): 3097-103, 2009 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19451434
4.
Phase I pharmacokinetic and pharmacodynamic study of Carboplatin and topotecan administered intravenously every 28 days to patients with malignant solid tumors.
Clin Cancer Res
; 15(13): 4475-83, 2009 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19531625
5.
Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.
J Clin Oncol
; 24(3): 467-75, 2006 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16421423
6.
Topoisomerase I levels in white blood cells of patients with ovarian cancer treated with paclitaxel-cisplatin-topotecan in a phase I study.
Anticancer Drugs
; 13(1): 87-91, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11914645